Global Thyroid Microwave Ablation Technology Exchange Conference (3rd Session) Successfully Held Online
July 25, 2024 — Baird Medical hosted the third session of its Global Thyroid Microwave Ablation Technology Exchange Conference, bringing together international thyroid specialists to discuss advancements in microwave ablation (MWA) and best practices in clinical settings. The event featured a series of presentations and lively discussions, focusing on the safety, efficacy, and management of MWA procedures.
Conference Highlights
The conference commenced with an Opening Address by Dr. Xiaoqing Pei from Sun Yat-sen University Cancer Center, setting the tone for an engaging session. He highlighted the significance of ongoing innovation in thyroid care and the need for continued collaboration across the global medical community.
Dr. Chengfang Zhu from The Ninth People’s Hospital affiliated to Shanghai JiaoTong University followed with a presentation on the "Management of Complications in Thyroid Thermal Ablation." Dr. Zhu shared strategies for minimizing procedural risks and maintaining high standards of patient safety, drawing on his extensive clinical experience.
Dr. Yunjun Wang from Fudan University, Shanghai Cancer Center, presented on "Indications and Technical Essentials of Thyroid Microcarcinoma Ablation." He discussed the optimal conditions for applying MWA in treating thyroid microcarcinomas and provided insights on improving ablation precision and outcomes.
Key Discussions
The open discussion session featured prominent international experts, including Dr. Jennifer Hong Kuo from Columbia University Medical Center and Dr. Alireza Falahati from Utah Endocrinology Associates. Both shared their perspectives on the evolving role of MWA in thyroid care, particularly focusing on "Patient Selection Criteria for MWA" and "Optimizing MWA for Complex Thyroid Nodules."
Dr. Stephanie L. Lee from Boston Medical Center and Dr. Gary S. Tse from UCLA Medical Center explored “Future Trends in MWA Technology,” emphasizing advancements in imaging and energy control. The session concluded with a Q&A segment, where participants exchanged practical advice on integrating MWA into diverse clinical environments.
Driving Global Innovation
The conference provided a platform for knowledge exchange among key opinion leaders (KOLs), contributing to a deeper understanding of MWA’s potential in thyroid disease management. By fostering these international discussions, Baird Medical continues to support the global development and application of minimally invasive thyroid treatments.
Disclaimer: This content is for informational purposes only and does not constitute a clinical recommendation. Please consult a qualified healthcare professional for advice tailored to individual cases.